Clinical Trials on Mean Platelet Volume in Finland
Total 27 results
-
Kati JärveläFinnish Cultural FoundationCompletedFluid Volume DisorderFinland
-
CardioKine Inc.Biogen; Cardiokine Biopharma, LLCCompletedHyponatremia With Excess Extracellular Fluid Volume | Hyponatremia With Normal Extracellular Fluid VolumeUnited States
-
Finnish Institute for Health and WelfareUniversity of Oslo; Academy of Finland; The Finnish Funding Agency for Technology... and other collaboratorsCompletedInflammation | Blood Pressure | Platelet FunctionFinland
-
The Miriam HospitalRecruitingSepsis | Septic Shock | Sepsis, Severe | Volume OverloadUnited States
-
Northwell HealthStaten Island University HospitalCompleted
-
CardioKine Inc.Biogen; Cardiokine Biopharma, LLCCompletedHyponatremia With Normal Extracellular Fluid VolumeUnited States, Canada, Germany, India, Poland, Belgium
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingSpinal Column TumorUnited States, Canada, Italy, Australia, China, Germany, Hungary, Japan, United Kingdom
-
GlaxoSmithKlineCompletedThrombocytopaeniaUnited States, Germany, Israel, Belgium, Finland, Ireland, Italy, Greece, India, Czech Republic, Hungary, Canada, Poland
-
Laboratoire français de Fractionnement et de BiotechnologiesCompletedVon Willebrand DiseaseNorway, Germany, Italy, Belgium, Czechia, Finland, Greece
-
OctapharmaActive, not recruitingChronic Immune ThrombocytopeniaUnited States
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Puerto Rico
-
ShireCompletedThrombocythemia, EssentialSpain, United Kingdom, Greece, Denmark, Italy, France, Finland, Norway, Sweden, Germany, Cyprus, Ireland, Netherlands, Portugal
-
American Thrombosis and Hemostasis NetworkTakedaActive, not recruiting
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlActive, not recruitingType 3 Von Willebrand's DiseaseFinland, France, Germany, Hungary, Iran, Islamic Republic of, Italy, Netherlands, Spain, Sweden, United Kingdom
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
Baylor College of MedicineBoston Children's Hospital; University of California, San FranciscoActive, not recruitingImmune ThrombocytopeniaUnited States
-
Boston Children's HospitalTerrana ITP Research FundCompletedImmune ThrombocytopeniaUnited States, Canada
-
Principia Biopharma, a Sanofi CompanyActive, not recruitingImmune Thrombocytopenia | Immune Thrombocytopenic PurpuraUnited States, Australia, Bulgaria, Canada, Czechia, Netherlands, Norway, United Kingdom
-
Sobi, Inc.Active, not recruitingImmune ThrombocytopeniaUnited States, France, Germany, Hungary, Poland, Russian Federation, Turkey, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedPurpura, Thrombocytopaenic, IdiopathicUnited Kingdom, Hong Kong, United States, Germany, Italy, Netherlands, Spain, Taiwan, Thailand, Canada, Denmark, Pakistan, Romania, Slovenia, Russian Federation, Slovakia, Sweden, Poland, China, New Zealand, Ukraine, Australia, Austria and more
-
American Thrombosis and Hemostasis NetworkNovo Nordisk A/S; Sanofi; Pfizer; Genentech, Inc.; CSL Behring; Hemophilia of Georgia... and other collaboratorsRecruitingHemophilia | Thrombosis | Thrombophilia | Sickle Cell Disease | Thalassemia | Bleeding Disorder | Von Willebrand Diseases | Factor IX Deficiency | Connective Tissue Disorder | Factor VIII Deficiency | Hematologic Disorder | Rare Bleeding Disorder | Platelet DisorderUnited States
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Taiwan, Italy, Poland, Peru, Canada, Denmark, Germany, Slovakia, Spain, United Kingdom, New Zealand, China, Greece, Hong Kong, Russian Federation, Austria, Netherlands, Czech Republic, France, India, Ukraine, Tunisia, F... and more
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
Incyte CorporationRecruitingMyelofibrosis | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome | Relapsed or Refractory Primary Myelofibrosis | Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis) | ET...United States, Spain, Japan, Italy, Finland, United Kingdom, Canada
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, China, Japan, France, Turkey, Germany, Israel, Poland, Belgium, Italy, Austria, Denmark, Finland, Norway
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, Belgium, France, Israel, China, Japan, Italy, Germany, Taiwan, Poland, Austria, Finland, Hungary, Norway, Romania, Turkey
-
Center for International Blood and Marrow Transplant...National Marrow Donor ProgramRecruitingAutoimmune Diseases | Hodgkin Lymphoma | Hematologic Malignancies | Acute Lymphoblastic Leukemia (ALL) | Non-hodgkin Lymphoma | Severe Aplastic Anemia | Inherited Disorders of Metabolism | Inherited Abnormalities of Platelets | Histiocytic Disorders | Acute Myelogenous Leukemia (AML or ANLL) | Other Acute... and other conditionsUnited States